SLXNW
Biomotion Sciences WarrantNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.26
52W High
$0.10
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biomotion Sciences Warrant
Biomotion Sciences Warrant (ticker: SLXNW) is affiliated with a biotechnology company dedicated to developing groundbreaking therapeutic solutions that target critical unmet medical needs. With a strong emphasis on rigorous research and development, the company is well-positioned for significant growth within the biopharmaceutical arena. As Biomotion Sciences advances through clinical trials and establishes strategic collaborations, it enhances its potential for substantial returns on investment amid the evolving healthcare landscape, driven by an expanding product pipeline.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-12.72M |
| Operating Margin | 0.00% |
| Return on Equity | -897.00% |
| Return on Assets | -123.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.86 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 159.80% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 414,620 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026